Historical Stock Price
THLD historical stock prices picture
THLD (THLD) has the following price history information. Looking back at THLD historical stock prices for the last five trading days, on July 26, 2017, THLD opened at $0.48, traded as high as $0.51 and as low as $0.48, and closed at $0.50. Trading volume was a total of 214.90K shares. On July 27, 2017, THLD opened at $0.50, traded as high as $0.51 and as low as $0.46, and closed at $0.50. Trading volume was a total of 659.40K shares. On July 28, 2017, THLD opened at $0.49, traded as high as $0.50 and as low as $0.47, and closed at $0.49. Trading volume was a total of 421.80K shares. On July 31, 2017, THLD opened at $0.48, traded as high as $0.50 and as low as $0.47, and closed at $0.50. Trading volume was a total of 227.10K shares. On August 01, 2017, THLD opened at $0.50, traded as high as $0.55 and as low as $0.47, and closed at $0.54. Trading volume was a total of 1.42M shares.

THLD Historical Stock Prices By Date:

THLD historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into THLD shares, starting with a $10,000 purchase of THLD, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/01/2014
End date: 08/01/2017
Start price/share: $4.81
End price/share: $0.54
Dividends collected/share: $0.00
Total return: -88.77%
Average Annual Total Return: -48.07%
Starting investment: $10,000.00
Ending investment: $1,122.94
Years: 3.34
Date Open High Low Close Volume
07/26/2017 $0.48 $0.51 $0.48 $0.50 214.90K
07/27/2017 $0.50 $0.51 $0.46 $0.50 659.40K
07/28/2017 $0.49 $0.50 $0.47 $0.49 421.80K
07/31/2017 $0.48 $0.50 $0.47 $0.50 227.10K
08/01/2017 $0.50 $0.55 $0.47 $0.54 1.42M
Molecular Templates is a biopharmaceutical company engaged in the tumor microenvironment to discover and develop therapeutic agents that selectively target tumor cells for the treatment of patients living with cancer. Co. is developing two therapeutic product candidates based on hypoxia-activated prodrug technology. Co. has completed two Phase 3 clinical trials of evofosfamide: TH-CR-406 conducted by Co. in patients with soft tissue sarcoma and MAESTRO conducted by Merck KGaA in patients with pancreatic cancer. Co.'s second product candidate, tarloxotinib, is a prodrug designed to selectively release a covalent (irreversible) EGFR tyrosine kinase inhibitor under hypoxic conditions.
Date Close
07/26/2017$0.50
07/27/2017$0.50
07/28/2017$0.49
07/31/2017$0.50
08/01/2017$0.54
THLD is categorized under the Healthcare sector; below are some other companies in the same sector:

THOR Historical Stock Prices
THRX Historical Stock Prices
TKAI Historical Stock Prices
TKMR Historical Stock Prices
TLB Historical Stock Prices
TLGT Historical Stock Prices
TLOG Historical Stock Prices
TMO Historical Stock Prices
TNDM Historical Stock Prices
TNXP Historical Stock Prices

Email EnvelopeFree THLD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


THLD Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.